Keyphrases
Meta-analysis
100%
Confidence Interval
100%
Systematic Meta-analysis
100%
In Vitro Synergy
100%
Carbapenems
100%
Polymyxin
100%
Combination Therapy
75%
Gram-negative Bacteria
75%
Antagonism
50%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Time-kill Study
50%
Resistance Development
50%
Baumannii
50%
Checkerboard
25%
Testing Method
25%
Antibiotic Resistance
25%
Bacterial Isolates
25%
Log Reduction
25%
Klebsiella Pneumoniae (K. pneumoniae)
25%
Fractional Inhibitory Concentration Index
25%
In Vitro Interactions
25%
Polymyxin B
25%
Mixed Effects
25%
Acinetobacter Baumannii (A. baumannii)
25%
Meropenem
25%
Doripenem
25%
Imipenem
25%
Antibiotic Combination
25%
Broad Search
25%
Conference Proceedings
25%
Publication Status
25%
Etest Method
25%
Carbapenem Resistance
25%
Checkerboard Assay
25%
Colistin B
25%
Time-kill Methods
25%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Carbapenem
100%
Carbapenem Derivative
100%
Polymyxin
100%
Pseudomonas aeruginosa
66%
Clinical Study
33%
Klebsiella pneumoniae
33%
Polymyxin B
33%
Imipenem
33%
Doripenem
33%
Meropenem
33%
Colistimethate
33%
Acinetobacter Baumannii
33%
Immunology and Microbiology
Polymyxin
100%
Pseudomonas aeruginosa
66%
Etest
66%
Colony Forming Unit S
33%
Colony-Forming Unit
33%
Fractional Inhibitory Concentration Index
33%
Klebsiella pneumoniae
33%
Colistin
33%
Acinetobacter Baumannii
33%
Polymyxin B
33%